STE · STERIS plc

Healthcare NYQ United States steris.com ↗
Val Gro Qua Mom Sta Cap P/S3.40 P/E Fwd P/E17.21 PEG1.79 52W –  RSI Target$263.12 (+24.8%) Beta0.91 Div1.19%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Devices Mentor, United States 17,937 employees
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 26 Overbought · 100
Signal Oversold
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
4Bearish
0Neutral

Key Signals 3

▲ Inv. Head & Shoulders Major reversal 2026-07-16 · $217.31
Inv. H&S neckline ~$217.31 broken — major bullish reversal
Learn more →
▲ Double Bottom Major reversal 2026-08-07 · $235.66
Two lows ~$210.84 — bullish reversal confirmed
Learn more →
▼ Double Top Major reversal 2026-09-03 · $229.36
Two peaks ~$240.87 — bearish reversal confirmed
Learn more →

Momentum Signals 7

▲ MACD Bullish Crossover 2026-05-14 · $215.34
▲ MACD Bullish Crossover 2026-06-05 · $211.72
▲ MACD Bullish Crossover 2026-06-25 · $210.6
▲ MACD Bullish Crossover 2026-07-27 · $218.4

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 04, 2026
Beat Rate 88%
Analyst Upside +24.8%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
88% 7/8 quarters
Wall Street Consensus
Price Target Range
$263.12 +24.8% upside
Low $232 High $280
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 44.42%Last 12 Months
Operating Margin 19.15%Last 12 Months
Return on Equity 11.39%Last 12 Months
Revenue Growth 7.30%Year over Year
Free Cash Flow 798.86MLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 28.31Most Recent Quarter
Current Ratio 1.91Most Recent Quarter
Cash 482.30MMost Recent Quarter
Total Debt 2.04BMost Recent Quarter
Net Debt Most Recent Quarter
How STE Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap20.55B
Enterprise Value22.13B
Trailing P/E25.99
Forward P/E17.21
PEG Ratio (5yr)1.79
Price/Sales (ttm)3.40
Price/Book (mrq)2.85
EV/Revenue3.67
EV/EBITDA13.49
Share Statistics
Avg Vol (3m)740.15K
Shares Outstanding97.50M
Float97.08M
% Held by Insiders0.31%
% Held by Institutions100.89%
Short Ratio3.48
Short % of Float2.51%
Profitability
Gross Margin44.42%
Operating Margin (ttm)19.15%
Profit Margin13.33%
Return on Assets (ttm)6.80%
Return on Equity (ttm)11.39%
Income Statement
Revenue (ttm)6.04B
Revenue Growth (yoy)7.30%
Gross Profit (ttm)2.68B
EBITDA1.64B
Net Income (ttm)805.00M
Diluted EPS (ttm)8.11
EPS Growth (yoy)14.00%
Balance Sheet
Total Cash (mrq)482.30M
Total Debt (mrq)2.04B
Debt / Equity (mrq)28.31
Current Ratio (mrq)1.91
Book Value / Share73.92
Operating CF (ttm)1.29B
Free Cash Flow (ttm)798.86M
Trading & Dividends
Beta (5Y)0.91
50-Day MA225.45
200-Day MA232.27
Fwd Dividend Yield1.21%
Payout Ratio30.81%
Income
Dividend Yield 1.19%Last 12 Months
Annual Rate 2.58Forward
Payout Ratio 30.81%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 30.81%
Monthly Dividends
Ownership Breakdown
Institutional 100.89% Insider 0.31%
Short Interest 2.51% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in STE in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value